Anton Malyshev

Anton Malyshev is a seasoned professional in the biopharmaceutical and AI sectors, currently serving as the Sr. Director of Portfolio Strategy at OPTIC, where leadership in portfolio strategy focuses on therapeutic asset evaluation and the integration of scientific, clinical, and commercial insights. Prior to this role, Anton co-founded and held the position of CEO at Lactocore Group, a preclinical biopharmaceutical company specializing in intranasally delivered therapeutics for CNS disorders. Educational qualifications include a Ph.D. in Physiology from Moscow State University, completion of the Startup Leadership Program at Global Innovation Labs in Boston, and an M.Sc. in Physiology from Moscow State University.